{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:34:55Z","timestamp":1792636495557,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.vaccine.2023.02.040","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T15:25:13Z","timestamp":1677770713000},"page":"2270-2279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The immunological effects of intradermal particle-based vaccine delivery using a novel microinjection needle studied in a human skin explant model"],"prefix":"10.1016","volume":"41","author":[{"given":"Manon","family":"Beaujean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rienke F.","family":"Uijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen D.","family":"Langereis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boccara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e8le","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Veldhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucille","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Bonduelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole N.","family":"van der Wel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joen","family":"Luirink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Pedruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Wissink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marien I.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behazine","family":"Combadi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.02.040_b0005","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4049\/jimmunol.2000703","article-title":"Effective and safe stimulation of humoral and cell-mediated immunity by intradermal immunization with a cyclic dinucleotide\/nanoparticle combination adjuvant","volume":"206","author":"Hernandez-Franco","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2023.02.040_b0010","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1016\/j.vaccine.2015.01.086","article-title":"Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts","volume":"33","author":"Koutsonanos","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.02.040_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.732298","article-title":"Specific protein antigen delivery to human langerhans cells in intact skin","volume":"12","author":"Rentzsch","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.02.040_b0020","series-title":"Smallpox and its eradication","author":"Fenner","year":"1988"},{"key":"10.1016\/j.vaccine.2023.02.040_b0025","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.vaccine.2013.12.033","article-title":"Bifurcated vaccination needle","volume":"32","author":"Artenstein","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.02.040_b0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2223\/1146","article-title":"Percutaneous or intradermal BCG vaccine?","volume":"80","author":"Bricks","year":"2004","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.vaccine.2023.02.040_b0035","first-page":"693","article-title":"Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine","volume":"78","author":"Briggs","year":"2000","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2023.02.040_b0040","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/j.vaccine.2008.03.095","article-title":"Intradermal vaccine delivery: will new delivery systems transform vaccine administration?","volume":"26","author":"Lambert","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.02.040_b0045","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/thx.54.9.762","article-title":"Administration of the BCG vaccination using the multipuncture method in schoolchildren: a comparison with the intradermal method","volume":"54","author":"Al Jarad","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2023.02.040_b0050","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/ajkd.2000.19099","article-title":"A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients","volume":"36","author":"Charest","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.vaccine.2023.02.040_b0055","doi-asserted-by":"crossref","first-page":"8833","DOI":"10.1016\/j.vaccine.2007.10.020","article-title":"Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system","volume":"25","author":"Laurent","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.02.040_b0060","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa043555","article-title":"Serum antibody responses after intradermal vaccination against influenza","volume":"351","author":"Belshe","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.02.040_b0065","doi-asserted-by":"crossref","first-page":"29368","DOI":"10.1038\/srep29368","article-title":"Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing","volume":"6","author":"Ng","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2023.02.040_b0070","doi-asserted-by":"crossref","first-page":"e2035693","DOI":"10.1001\/jamanetworkopen.2020.35693","article-title":"Immunogenicity and safety of reduced-dose intradermal vs intramuscular influenza vaccines: a systematic review and meta-analysis","volume":"4","author":"Egunsola","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2023.02.040_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.645210","article-title":"Vaccine inoculation route modulates early immunity and consequently antigen-specific immune response","volume":"12","author":"Rosenbaum","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.02.040_b0080","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4161\/hv.7.8.16274","article-title":"Transcutaneous and intradermal vaccination","volume":"7","author":"Combadiere","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2023.02.040_b0085","doi-asserted-by":"crossref","first-page":"e10818","DOI":"10.1371\/journal.pone.0010818","article-title":"Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial","volume":"5","author":"Combadiere","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.02.040_b0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/exd.12589","article-title":"Hair follicle targeting, penetration enhancement and Langerhans cell activation make cyanoacrylate skin surface stripping a promising delivery technique for transcutaneous immunization with large molecules and particle-based vaccines","volume":"24","author":"Vogt","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.vaccine.2023.02.040_b0095","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1172\/JCI200419655","article-title":"Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells","volume":"113","author":"Hunger","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2023.02.040_b0100","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.jid.5700226","article-title":"40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin","volume":"126","author":"Vogt","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.vaccine.2023.02.040_b0105","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI32282","article-title":"Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages","volume":"117","author":"Zaba","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2023.02.040_b0110","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.immuni.2008.07.013","article-title":"Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells","volume":"29","author":"Klechevsky","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2023.02.040_b0115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.immuni.2009.04.016","article-title":"Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12","volume":"31","author":"Schmitt","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2023.02.040_b0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2013.12.022","article-title":"Particle-based transcutaneous administration of HIV-1 p24 protein to human skin explants and targeting of epidermal antigen presenting cells","volume":"176","author":"Rancan","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2023.02.040_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.05.002","article-title":"Recent advances in microneedle composites for biomedical applications: advanced drug delivery technologies","volume":"103","author":"Sharma","year":"2019","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.vaccine.2023.02.040_b0130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.vaccine.2011.11.020","article-title":"Devices for intradermal vaccination","volume":"30","author":"Kis","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.02.040_b0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2018.08.042","article-title":"Preparation, properties and challenges of the microneedles-based insulin delivery system","volume":"288","author":"Chen","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2023.02.040_b0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10558-010-9100-5","article-title":"Design, fabrication and analysis of silicon hollow microneedles for transdermal drug delivery system for treatment of hemodynamic dysfunctions","volume":"10","author":"Ashraf","year":"2010","journal-title":"Cardiovasc Eng"},{"key":"10.1016\/j.vaccine.2023.02.040_b0145","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1080\/21645515.2016.1187343","article-title":"Fluzone(R) intra-dermal (Intanza(R)\/Istivac(R) Intra-dermal): an updated overview","volume":"12","author":"Bragazzi","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.02.040_b0150","first-page":"134","article-title":"Acceptability of fluzone intradermal vaccine to patients and vaccine administrators","volume":"113","author":"Foy","year":"2013","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.vaccine.2023.02.040_b0155","unstructured":"Hisayoshi Yamoto HY, Yuichi Satou, Hajime Yagi, all of Kanagawa (JP) method of forming monocrystalline silicon layer, method for manufacturing semiconductor device, and semconductor device. In: States U, editor. Sony Corporation, Tokyo (JP); 2002."},{"key":"10.1016\/j.vaccine.2023.02.040_b0160","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.4049\/jimmunol.179.11.7692","article-title":"Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo","volume":"179","author":"Alaniz","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2023.02.040_b0165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/bjd.16721","article-title":"Interleukin-32 promotes detachment and activation of human Langerhans cells in a human skin explant model","volume":"179","author":"Gonnet","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.vaccine.2023.02.040_b0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejps.2015.02.018","article-title":"In vitro skin models as a tool in optimization of drug formulation","volume":"75","author":"Flaten","year":"2015","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.vaccine.2023.02.040_b0175","unstructured":"Johan Willem Berenschot JMW, Niels Roelof Tas, Meint Jelle DeBoer. Microneedle, microneedle array and production method therefor. In: States U, editor; 2017."},{"key":"10.1016\/j.vaccine.2023.02.040_b0180","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.vaccine.2015.03.010","article-title":"Salmonella outer membrane vesicles displaying high densities of pneumococcal antigen at the surface offer protection against colonization","volume":"33","author":"Kuipers","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.02.040_b0185","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00281-17","article-title":"Th17-mediated cross protection against pneumococcal carriage by vaccination with a variable antigen","volume":"85","author":"Kuipers","year":"2017","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2023.02.040_b0190","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1128\/AEM.01941-14","article-title":"Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach","volume":"80","author":"Daleke-Schermerhorn","year":"2014","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2023.02.040_b0195","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0344-0338(11)80649-7","article-title":"Quantitative analysis of the immune cells in the anal mucosa","volume":"191","author":"Gervaz","year":"1995","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.vaccine.2023.02.040_b0200","doi-asserted-by":"crossref","first-page":"e12410","DOI":"10.1371\/journal.pone.0012410","article-title":"Changes in human langerhans cells following intradermal injection of influenza virus-like particle vaccines","volume":"5","author":"Pearton","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.02.040_b0205","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/jid.2011.346","article-title":"Intradermal immunization triggers epidermal Langerhans cell mobilization required for CD8 T-cell immune responses","volume":"132","author":"Liard","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.vaccine.2023.02.040_b0210","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.2147\/RMHP.S309707","article-title":"Intradermal vaccination: a potential tool in the battle against the COVID-19 pandemic?","volume":"14","author":"Migliore","year":"2021","journal-title":"Risk Manag Healthc Policy"},{"key":"10.1016\/j.vaccine.2023.02.040_b0215","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.vaccine.2015.12.058","article-title":"Intradermal vaccination with un-adjuvanted sub-unit vaccines triggers skin innate immunity and confers protective respiratory immunity in domestic swine","volume":"34","author":"Le Luduec","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.02.040_b0220","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.jid.2017.04.016","article-title":"Critical role for skin-derived migratory DCs and langerhans cells in TFH and GC responses after intradermal immunization","volume":"137","author":"Levin","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.vaccine.2023.02.040_b0225","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1172\/JCI116873","article-title":"Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization","volume":"92","author":"Lenz","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2023.02.040_b0230","doi-asserted-by":"crossref","first-page":"e0143519","DOI":"10.1371\/journal.pone.0143519","article-title":"Phenotypic and functional properties of human steady state CD14+ and CD1a+ antigen presenting cells and epidermal langerhans cells","volume":"10","author":"Fehres","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.02.040_b0235","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.immuni.2014.08.006","article-title":"Human dermal CD14(+) cells are a transient population of monocyte-derived macrophages","volume":"41","author":"McGovern","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2023.02.040_b0240","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.immuni.2012.04.012","article-title":"Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells","volume":"37","author":"Haniffa","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2023.02.040_b0245","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.immuni.2013.04.011","article-title":"IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses","volume":"38","author":"Schlitzer","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2023.02.040_b0250","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.immuni.2011.06.005","article-title":"Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses","volume":"35","author":"Igyarto","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2023.02.040_b0255","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0142-9612(88)90033-6","article-title":"Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage","volume":"9","author":"Tabata","year":"1988","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2023.02.040_b0260","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41541-021-00359-8","article-title":"Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges","volume":"6","author":"Lee","year":"2021","journal-title":"NPJ Vacc"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23001755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23001755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:26:31Z","timestamp":1759404391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23001755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":52,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0264410X23001755"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.02.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunological effects of intradermal particle-based vaccine delivery using a novel microinjection needle studied in a human skin explant model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.02.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}